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Endovascular vs open repair for ruptured
abdominal aortic aneurysm
April E. Nedeau, MD,a Frank B. Pomposelli, MD,a Allen D. Hamdan, MD,a Mark C. Wyers, MD,a
Richard Hsu, MD, PhD,b Teviah Sachs, MD,a Jeffrey J. Siracuse, MD,a and
Mark L. Schermerhorn, MD,a Boston, Mass; and Danbury, Conn
Objective: Endovascular repair (EVAR) of ruptured abdominal aortic aneurysm (rAAA) has become first-line therapy at
our institution and is performed under a standardized protocol. We compare perioperative mortality, midterm survival,
and morbidity after EVAR and open surgical repair (OSR).
Methods: Records were retrospectively reviewed from May 2000 to September 2010 for repair of infrarenal rAAAs.
Primary end points included perioperative mortality and midterm survival. Secondary end points included acute limb
ischemia, length of stay, ventilator-dependent respiratory failure, myocardial infarction, renal failure, abdominal
compartment syndrome, and secondary intervention. Statistical analysis was performed using the t-test, 2 test, the Fisher
exact test, and logistic regression calculations. Midterm survival was assessed with Kaplan-Meier analysis and Cox
proportional hazard models.
Results: Seventy-four infrarenal rAAAs were repaired, 19 by EVAR and 55 by OSR. Despite increased age and
comorbidity in the EVAR patients, perioperative mortality was 15.7% for EVAR, which was significantly lower than the
49% for OSR (odds ratio, 0.19; 95% CI, 0.05-0.74; P .008). Midterm survival also favored EVAR (hazard ratio, 0.40;
95% CI, 0.21-0.77; P .028, adjusted for age and sex). Mean follow-up was 20 months, and 1-year survival was 60% for
EVAR vs 45% for OSR. Mean length of stay for patients surviving >1 day was 10 days for EVAR and 21 days for OSR
(P  .004). Ventilator-dependent respiratory failure was 5% in the EVAR group vs 42% for OSR (odds ratio, 0.08; 95%
CI, 0.01-0.62; P  .001).
Conclusions: EVAR of rAAA has a superior perioperative survival advantage and decreased morbidity vs OSR. Although
not statistically significant, overall survival favors EVAR. We recommend that EVAR be considered as the first-line
treatment of rAAAs and practiced as the standard of care. ( J Vasc Surg 2012;56:15-20.)
A
t
d
s
t
8
p
u
t
r
E
i
e
d
l
W
a
M
a
t
r
c
c
fEndovascular repair (EVAR) of abdominal aortic aneu-
rysms (AAAs) was introduced in the 1990s as an alternative
to open surgical repair (OSR) for patients with high oper-
ative risk.1 Randomized, controlled trials (RCT) report
lower perioperative morbidity and mortality with elective
EVAR compared with OSR.2-4 Endovascular repair for
rAAA (rEVAR) was introduced in 1994 byMarin et al5 and
has been increasing nationwide6 since the first case series of
12 patients was reported by Ohki et al.7,8 Hinchliffe et al9
published the only RCT in 2006, demonstrating equivalent
results and challenging the benefit of rEVAR. Lack of
statistical power due to small sample size is a frequently
cited criticism. Although a few RCTs are ongoing, such as
the Immediate Management of the Patient with Ruptured
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rial, data from RCTs are not yet available.
Data from the Nationwide Inpatient Sample (NIS)
emonstrate reduced overall mortality after rAAA repair
ince EVAR was introduced nationally,10-12 and retrospec-
ive series demonstrate a potential survival advantage, with
% to 40% mortality.11-13 Prospective trials have shown
otential benefit but are limited by sample size.14-17
Early reports of rEVARwere favorable when performed
nder standardized protocols that used rEVAR as first-line
herapy. Mehta et al18 reported an 18% mortality rate after
EVAR compared with the traditional 40% to 50% for OSR.
VAR is first-line therapy for patients with rAAAs at our
nstitution, and a formal protocol is practiced to expedite
valuation and treatment. The purpose of this study was to
etermine if perioperative morbidity and mortality are
ower after rEVAR, compared with OSR, at our institution.
e also evaluated length of stay (LOS), midterm survival,
nd institutional use of rEVAR during the past 5 years.
ETHODS
We performed a retrospective review of rAAA repairs
t Beth Israel Deaconess Medical Center from May 2000
o September 2010. Suprarenal and juxtarenal aneu-
ysms were excluded. Preoperative characteristics were
ompared between rEVAR and OSR, including age, sex,
oronary artery disease, and history of congestive heart
ailure, atrial fibrillation, chronic obstructive pulmonary
isease, chronic renal insufficiency (glomerular filtration
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July 201216 Nedeau et alrate 60 mL/min/1.73 m2), hypertension, and diabetes.
Primary end points included perioperative mortality (in-
hospital or 30 days) and midterm survival. Our rAAA
protocol was initiated in 2007. Perioperative mortality was
compared between rEVAR and OSR patients before and
after the protocol was initiated.
Secondary end points included LOS, acute renal failure
requiring dialysis, ventilator-dependent respiratory failure
(VDRF) requiring 7 days of ventilator support, acute
limb or acute mesenteric ischemia, myocardial infarction
(MI), abdominal compartment syndrome, and secondary
intervention for wound infection or seroma, bowel resec-
tion, thrombectomy, conversion toOSR, coil embolization
of type II endoleak, and closure of abdominal wounds.
Preoperative hemodynamic stability and intraoperative es-
timated blood loss (EBL) were assessed. Because our pro-
tocol includes permissive hypotension, permitting a systolic
blood pressure (SBP) 100 mm Hg, the definition of
instability included SBP 90 mm Hg, administration of
vasoactive medications to maintain SBP 90 mm Hg,
intubation before arrival to the operating room, or SBP
100 mm Hg with depressed mental status.
Our rupture protocol involves notification through a
central paging system of on-call staff, including vascular/
endovascular surgeons, cardiovascular anesthesiologists,
endovascular nurses with catheter-based experience, and
radiology technicians. Early notification facilitates immedi-
ate preparation for direct patient transfer to the operating
suite on arrival, if necessary. The protocol is designed to
enable rapid evaluation of aneurysm anatomy and transfer
to the hybrid operating/endovascular suite. Communica-
tion between departments for expeditious treatment is
paramount and has been emphasized in previously pub-
lished protocols.18 If the patient is hemodynamically stable
enough to delay surgery, direct transfer to the computed
tomography (CT) scanner occurs with surgical staff in
attendance. If the patient’s anatomy is favorable for
rEVAR, grafts are sized and selected from available inven-
tory, which contains most of the available components of
two different stent graft systems. Patients who are too
unstable to undergo a CT scan are transferred directly from
the helicopter or ambulance to the endovascular suite.
Ultrasound-guided access into the common femoral
arteries is achieved before induction of anesthesia to allow
for sheath andwire placement into the aorta. Aortic balloon
occlusion is initiated, if hemodynamic instability is present,
as previously described.19,20 Two Perclose ProGlide
suture-mediated closure devices (Abbott Laboratories, Ab-
bott Park, Ill) are fired (Perclose technique) to avoid the
need for surgical femoral artery exposure. We routinely use
ultrasound-guided access and the Perclose technique dur-
ing elective EVAR repairs to facilitate rapid and consistent
technical results during rAAA repair. If unstable, percuta-
neous closure can be delayed until the repair has been
completed.
The main body device is delivered through the femoral
artery sheath, contralateral to the side with the occlusion
balloon and deployed after the balloon is deflated and withdrawn. If needed, an additional occlusion balloon can
e placed through the main body device once it is deployed
o maintain proximal control while cannulating and de-
loying the contralateral iliac limb. Zenith Flex (Cook,
loomington, Ind) and Gore Excluder (W. L. Gore and
ssociates, Flagstaff, Ariz) endografts were used primarily
o perform rEVAR and were selected based on surgeon
xperience and preference.
After graft deployment and fixation, the proximal oc-
lusion balloon is deflated and removed, and an aortogram
s performed and reviewed for endoleak. The sheaths are
emoved over a wire, and Perclose sutures are pushed down
ver a wire left in the femoral artery. If hemostasis is
chieved, the wire is removed and the sutures are secured. If
ersistent bleeding occurs, additional Perclose ProGlide
evices may be deployed, or the sheath may be replaced for
emostasis, allowing subsequent open repair.
OSR of rAAAs is performed in a standard fashion with
midline transperitoneal or retroperitoneal incision, based
n surgeon preference. If a transperitoneal approach is
erformed, the abdominal wall is frequently left open to
inimize the development of abdominal compartment
yndrome. Closure of the abdomen is usually delayed 48 to
2 hours.
Statistical analysis of preoperative characteristics, peri-
perative outcomes, and mortality was performed using
-test, 2 test, the Fisher exact test, and logistic regression
alculations. Midterm survival was assessed with Kaplan-
eier analysis and Cox proportional hazard models. Statis-
ical analysis was performed with SAS software (SAS Insti-
ute Inc, Cary, NC). Statistical significance was assigned at
he value of P  .05.
ESULTS
Between May 2000 and September 2010, 74 rAAAs
ere repaired, comprising 19 rEVAR and 55OSR. Patients
ere generally excluded for an infrarenal aortic neck 5
m, diameter greater than the largest available main body
raft at the time performed, or severe iliac occlusive arterial
isease. Two rAAAs were repaired with EVAR before our
rotocol was initiated in 2007. The average patient age was
8 years for rEVAR and 76 years for OSR (P  .44).
omen comprised 26% of rEVAR and 49% of OSR (odds
atio [OR], 0.37; 95% confidence interval [CI], 0.12-1.2;
 .08). Preoperative characteristics and comorbidities of
atients undergoing EVAR and OSR are listed in Table I.
omorbidities were not significantly different between the
wo groups, except chronic renal insufficiency, which was
2% for rEVAR and 9% for OSR (OR, 7.3; 95% CI, 2.0-27;
 .002) and congestive heart failure, at 47% for rEVAR
nd 15% for OSR (OR, 5.3; 95% CI, 1.6-17, P  .005).
uptures were considered unstable in 50% of patients in the
EVAR group vs 57% in the OSR group (OR, 0.85; 95%
I, 0.3-2.3; P  .75). Balloon occlusion was required in
1% of rEVAR patients and in 16% of OSR patients (P 
32). Since initiation of the formal protocol in 2007, one
atient was deemed too unstable to undergo a CT scan and
as transported directly to the hybrid operating room. An
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Volume 56, Number 1 Nedeau et al 17occlusion balloon was inflated within the aorta, an aorto-
gram was performed, and the aneurysm was successfully
excluded with a bifurcated endograft. However, the patient
died on the table due to cardiac arrest.
Perioperative mortality was 15.7% for rEVAR and 49%
for OSR (OR, 0.19; 95% CI, 0.05-0.74; P  .008). Mid-
term survival also favored rEVAR (hazard ratio, 0.40; 95%
CI, 0.21-0.77, P  .028, adjusted for age and sex, Fig 1).
Mean follow-up was 20 months, and 1-year survival was
60% for EVAR vs 45% for OSR. Mean LOS for patients
surviving 1 day was 10 days for rEVAR and 21 days for
OSR (P  .004).
Postoperative complications, including acute renal fail-
ure requiring hemodialysis, acute limb ischemia, mesenteric
ischemia, and MI, were similar between the two groups
(Table II). One MI occurred after rEVAR resulting in
death, and four MIs occurred after OSR, with one death.
One rEVAR was complicated by acute limb ischemia, rec-
ognized before leaving the operating room. A common
femoral thrombectomy and patch angioplasty was per-
formed, resulting in limb salvage. One OSR was compli-
cated by bilateral limb ischemia, requiring bilateral lower
extremity thrombectomy. Limb salvage was achieved, but
the patient died several days later of multiorgan system
failure. VDRF was significantly lower in the rEVAR group,
with a rate of 5% compared to 42% for OSR (OR, 0.08; 95%
CI, 0.01-0.62; P .001). EBL was 0.4 liters in the rEVAR
group and 2.9 liters in the OSR group (P  .0005). The
number of packed red blood cell (pRBC) units transfused
was also compared because calculated blood loss for OSR
patients includes both internal hematoma and operative
hemorrhage, whereas only externalized blood was calcu-
lated for rEVAR. An average of 3.42 units of pRBC were
transfused for rEVAR vs 10.4 units for OSR (P .00005).
Secondary interventions were required in 37% of
rEVAR patients, including wound debridement for infec-
Table I. Preoperative characteristics and comorbidities of
patients undergoing endovascular repair (EVAR) and
open surgical repair (OSR) for ruptured abdominal aortic
aneurysms (rAAAs)
Characteristicsa EVAR OSR P
Age, years 78.2 (56-96) 76.3 (58-88) .44
Female sex 26.3 49.1 .08
Coronary artery disease 52.6 38.2 .27
Congestive heart failure 47.4 14.6 .005
Chronic renal insufficiencyb 42.1 9.1 .002
Hemodynamic instability 50.0 57.1 .75
Hypertension 73.7 65.5 .51
Chronic obstructive
pulmonary disease
26.3 23.6 .82
Atrial fibrillation 36.8 18.2 .11
Diabetes 15.8 12.7 .74
aContinuous data are presented as mean (range) and categoric data as
percentage.
bDefined as glomerular filtration rate of 60 mL/min/1.73m2.tion or seroma, coil embolization of type II endoleak, and gonversion to OSR, compared with 33% of OSR patients
P  .74), who required colectomy for mesenteric isch-
mia, thrombectomy for acute limb ischemia, graft revi-
ion for infection, and abdominal wound closure for
ompartment syndrome. Delayed closure of the abdom-
nal wound occurred in 25% of OSR patients, often
rophylactically, according to surgeon preference,
hereas none of the rEVAR patients underwent decom-
ressive laparotomy (P  .57).
The annual combined volume of rEVAR and OSR for
AAA is reported in Fig 2. EVAR use has been increasing
ince the rAAA protocol was initiated in 2007. Overall
ortality was 54.1% before the protocol (2000-2007)
ompared with 27% after the protocol (2007-2010; OR
.29; 95% CI, 1.2-8.7; P  .014).
There were no immediate conversions in the rEVAR
roup. One patient underwent elective conversion 1
onth after rEVAR because of a small type I endoleak
ecognized on completion aortogram. Although no extrav-
sation was visualized, there was concern for potential,
ersistent aneurysm sac pressurization. After optimizing
ardiac and pulmonary function, elective OSR was per-
ormed. The patient is alive and has recently recovered from
he elective repair of a thoracic aneurysm. A second patient
ith an unrecognized type I endoleak after rEVAR pre-
ented with aortic rupture 1 month after repair. An OSR
as performed. The patient was discharged on postopera-
ive day 28 but died on day 38.
ISCUSSION
Previous RCTs demonstrate lower rates of morbidity
nd mortality in patients undergoing elective EVAR com-
ared with OSR counterparts.21-23 Currently, a growing
umber of single-institution studies and national and inter-
ational reviews report that perioperative mortality is also
ower for patients undergoing rEVAR.13,18,24-26 Our insti-
ution reflects the nationwide trend of increasing rEVAR
se, which presently is 65% of rAAA repairs. However,
ur rEVAR repairs are performed under a formal protocol
hat includes availability of endovascular staff, rapid evalu-
tion of aneurysm anatomy, a hybrid operating room suite,
nd priority toward rEVAR.6,27 These resources are re-
uired to practice under a similar protocol and may be
ustified by an adequate volume of rAAA, as well as other
ascular emergencies treated with a catheter-based inter-
ention. For this reason, it may be appropriate to centralize
AAA repair to tertiary centers that are able to provide these
pecialized resources. EVAR for rAAA under this standard-
zed protocol resulted in lower rates of perioperative mor-
ality, which was 15.7% for rEVAR and 49% for OSR. This
s comparable to results published by Mehta et al18 of 18%
VAR and 51% OSR. Our mortality rate was more than
hree times lower in the rEVAR group, despite higher rates
f preoperative chronic renal insufficiency and congestive
eart failure.
Hinchliff et al9 published results from a RCT in 2006
ith equivalent mortality in rEVAR (53%) and OSR (53%)
roups. However, more than two-thirds of patients were
b
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July 201218 Nedeau et alexcluded from the study because of hemodynamic instabil-
ity or staff unavailability. There were 13 patients in the
rEVAR group and only 11 completed rEVAR, due to OSR
Fig 1. Kaplan-Meier curves show survival analysis of pa
repair (OSR) for ruptured abdominal aortic aneurysms (
EVAR and 45% for OSR (adjusted hazard ratio, 0.40; P
Table II. Perioperative outcomes for patients undergoing
endovascular repair (EVAR) and open surgical repair (OSR)
for ruptured abdominal aortic aneurysms (rAAAs)
Perioperative
outcomes EVAR OSR OR (95% CI) P
Perioperative
mortality, %
15.7 49.1 0.19 (0.05-0.74) .008
Length of stay
1 day,
average days
9.6 20.5 .004
VDRF, % 5.3 41.8 0.07 (0.01-0.62) .001
ARF requiring
dialysis, %
10.5 14.6 0.69 (0.13-3.6) .65
Acute limb
ischemia, %
5.3 5.5 0.96 (0.09-9.9) .97
Mesenteric
ischemia, %
5.3 9.1 0.56 (0.061-5.1) .58
Myocardial
infarction, %
5.3 10.9 0.45 (0.05-4.0) .44
Estimated blood
loss, liters
0.40  0.29 2.9  1.7 .0005
Secondary
intervention, %
36.8 32.7 1.20 (0.4-3.6) .74
Delayed
abdominal
wound
closure, %
0 25 0.74 (0.3-1.7) .57
ARF, Acute renal failure; CI, confidence interval; OR, odds ratio; VDRF,
ventilator-dependent respiratory failure.crossover or preoperative death. Previous studies published fly Giles et al10,24 used the American College of Surgeons
ational Surgical Quality Improvement Program (NSQIP)
nd NIS databases to examine perioperative outcomes and
eported a perioperative survival advantage for rEVAR,
lbeit higher mortality rates of 24% for NSQIP and 39.9%
or NIS.6 Although the NIS study did not have access to
emodynamic data or aneurysm anatomy, potentially con-
ributing to selection bias, the NSQIP study did include
emodynamic parameters in a limited fashion.
Criticism toward similar studies has been directed at the
mbalance of hemodynamically stable patients, with more
avorable aneurysm anatomy, in the rEVAR cohorts. We
emonstrate a similar percentage of hemodynamic instabil-
ty in both groups, as well as exclusion of juxtarenal or
uprarenal aortic aneurysms in theOSR cohort. Giles et al10
eported decreased total AAA- and rAAA-related mortality
n the post-EVAR era using the NIS database. Overall
AAA mortality before rEVAR use and initiation of the
upture protocol was 54%, compared with the postprotocol
verall mortality of 27%. This suggests that our improved
erioperative mortality is not due to the selection of pa-
ients with favorable anatomy or hemodynamics.
Postoperative complications reflecting technical differ-
nces between rEVAR and OSR, such as acute limb and
esenteric ischemia, were similar. Significantly more
omenwere treated withOSR than rEVAR. The reason for
his is unclear from our data; however, this may be due to a
maller iliac diameter or less favorable aortic neck anatomy.
OS and VDRF were much lower in the rEVAR group,
ossibly as a result of less intraoperative blood loss, smaller
ostoperative fluid shifts, and reduced production of in-
s treated with endovascular (EVAR) and open surgical
s) during a 2-year period. Survival at 1 year is 60% for
8).tient
rAAAammatory mediators. EVAR may also expedite recovery
r
t
i
e
i
O
f
C
u
t
e
f
r
c
A
C
A
D
W
C
F
S
O
O
R
or ru
JOURNAL OF VASCULAR SURGERY
Volume 56, Number 1 Nedeau et al 19and lessen VDRF by reducing pain associated with large
abdominal incisions.
None of the rEVAR patients required laparotomy for
compartment syndrome, which may be because we require
evidence of elevated inspiratory peak airway pressures or
marginal urinary output combined with bladder pressures
30 mm H2O. Delayed abdominal closure occurred in
25% of OSR patients for compartment syndrome. How-
ever, this was frequently performed prophylactically ac-
cording to surgeon preference and therefore shows a bias
toward rEVAR.We agree with prior suggestions that a high
index of suspicion should be maintained to allow prompt
decompressive laparotomy if there is evidence of compart-
ment syndrome.
Overall survival curves show superiority for rEVAR vs
OSR (hazard ratio, 0.40; 95% CI, 0.21-0.77). Survival at 1
year was not statistically significant, likely due to small
numbers of patients with 1-year follow-up. Although the
midterm survival benefit is not as large as the perioperative
survival, it is still significant. Ongoing rEVAR mortality is
observed past the perioperative period and increased mor-
tality risk persists until 3 months. Characterization of
these patients may help identify those who are able to
survive rEVAR but who decompensate during recovery
from the rupture event due to comorbid illnesses. We
believe this hypothesis is supported by the findings of
Egorova et al,28 who published similar results after review
of the Medicare Inpatient Standard Analytical File, includ-
ing43,000 patients. Late survival (90 days) benefit was
not as pronounced as in the perioperative period but was
significant when cohorts were matched. Survival advantage
persisted out to 4 years of follow-up.28
Our study is limited by small sample size and short
Fig 2. Ruptured abdominal aortic aneurysm (AAA)
aneurysm repair (EVAR) vs open surgical repair (OSR) ffollow-up. Nonetheless, we were able to duplicate theesults published by similar institutions and demonstrated
he feasibility of rEVAR when performed under a standard-
zed protocol. Institutions should have significant experi-
nce with elective EVAR as well as the infrastructure and
nventory to create a standardized treatment algorithm.
ur study is retrospective and not randomized to control
or bias.
ONCLUSIONS
Ongoing debate regarding the need for RCTs contin-
es, but given the mounting evidence for survival advan-
age in patients undergoing rEVAR, RCTs may be unnec-
ssary. Given the superior perioperative survival advantage,
avorable overall survival, and decreased morbidity of
EVAR, we recommend it be practiced as the standard of
are for patients with rAAAs.
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